Your browser doesn't support javascript.
loading
Fluorescence Lifetime Imaging and Spectroscopic Co-Validation for Protoporphyrin IX-Guided Tumor Visualization in Neurosurgery.
Reichert, David; Erkkilae, Mikael T; Gesperger, Johanna; Wadiura, Lisa I; Lang, Alexandra; Roetzer, Thomas; Woehrer, Adelheid; Andreana, Marco; Unterhuber, Angelika; Wilzbach, Marco; Hauger, Christoph; Drexler, Wolfgang; Kiesel, Barbara; Widhalm, Georg; Leitgeb, Rainer A.
Afiliação
  • Reichert D; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Erkkilae MT; Christian Doppler Laboratory OPTRAMED, Medical University of Vienna, Vienna, Austria.
  • Gesperger J; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Wadiura LI; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Lang A; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Roetzer T; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Woehrer A; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Andreana M; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Unterhuber A; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Wilzbach M; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Hauger C; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Drexler W; Advanced Development Microsurgery, Carl Zeiss Meditec AG, Oberkochen, Germany.
  • Kiesel B; Advanced Development Microsurgery, Carl Zeiss Meditec AG, Oberkochen, Germany.
  • Widhalm G; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
  • Leitgeb RA; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
Front Oncol ; 11: 741303, 2021.
Article em En | MEDLINE | ID: mdl-34595120
ABSTRACT
Maximal safe resection is a key strategy for improving patient prognosis in the management of brain tumors. Intraoperative fluorescence guidance has emerged as a standard in the surgery of high-grade gliomas. The administration of 5-aminolevulinic acid prior to surgery induces tumor-specific accumulation of protoporphyrin IX, which emits red fluorescence under blue-light illumination. The technology, however, is substantially limited for low-grade gliomas and weakly tumor-infiltrated brain, where low protoporphyrin IX concentrations are outweighed by tissue autofluorescence. In this context, fluorescence lifetime imaging has shown promise to distinguish spectrally overlapping fluorophores. We integrated frequency-domain fluorescence lifetime imaging in a surgical microscope and combined it with spatially registered fluorescence spectroscopy, which can be considered a research benchmark for sensitive protoporphyrin IX detection. Fluorescence lifetime maps and spectra were acquired for a representative set of fresh ex-vivo brain tumor specimens (low-grade gliomas n = 15, high-grade gliomas n = 80, meningiomas n = 41, and metastases n = 35). Combining the fluorescence lifetime with fluorescence spectra unveiled how weak protoporphyrin IX accumulations increased the lifetime respective to tissue autofluorescence. Infiltration zones (4.1ns ± 1.8ns, p = 0.017) and core tumor areas (4.8ns ± 1.3ns, p = 0.040) of low-grade gliomas were significantly distinguishable from non-pathologic tissue (1.6ns ± 0.5ns). Similarly, fluorescence lifetimes for infiltrated and reactive tissue as well as necrotic and core tumor areas were increased for high-grade gliomas and metastasis. Meningioma tumor specimens showed strongly increased lifetimes (12.2ns ± 2.5ns, p = 0.005). Our results emphasize the potential of fluorescence lifetime imaging to optimize maximal safe resection in brain tumors in future and highlight its potential toward clinical translation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2021 Tipo de documento: Article